ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31692-10mM(1mLinDMSO) |
|
17680-84-1 |
Homoplantaginin
|
0 | C22H22O11 | |
GC31691-25mg |
|
287194-41-6 |
(+)-DHMEQ ((1R,2R,6R)-Dehydroxymethylepoxyquinomicin)
|
0 | C13H11NO5 | |
GC31691-10mg |
|
287194-41-6 |
(+)-DHMEQ ((1R,2R,6R)-Dehydroxymethylepoxyquinomicin)
|
0 | C13H11NO5 | |
GC31691-5mg |
|
287194-41-6 |
(+)-DHMEQ ((1R,2R,6R)-Dehydroxymethylepoxyquinomicin)
|
0 | C13H11NO5 | |
GC31691-2mg |
|
287194-41-6 |
(+)-DHMEQ ((1R,2R,6R)-Dehydroxymethylepoxyquinomicin)
|
0 | C13H11NO5 | |
GC31691-10mM(1mLinDMSO) |
|
287194-41-6 |
(+)-DHMEQ ((1R,2R,6R)-Dehydroxymethylepoxyquinomicin)
|
0 | C13H11NO5 | |
GC31690-100mg |
|
743461-65-6 |
Batefenterol (GSK961081)
|
0 | C40H42ClN5O7 | |
GC31690-50mg |
|
743461-65-6 |
Batefenterol (GSK961081)
|
0 | C40H42ClN5O7 | |
GC31690-10mg |
|
743461-65-6 |
Batefenterol (GSK961081)
|
0 | C40H42ClN5O7 | |
GC31690-5mg |
|
743461-65-6 |
Batefenterol (GSK961081)
|
0 | C40H42ClN5O7 | |
GC31690-10mM(1mLinDMSO) |
|
743461-65-6 |
Batefenterol (GSK961081)
|
0 | C40H42ClN5O7 | |
GC31689-50mg |
|
936350-00-4 |
Fiboflapon (GSK2190915)
|
0 | C38H43N3O4S | |
GC31689-10mg |
|
936350-00-4 |
Fiboflapon (GSK2190915)
|
0 | C38H43N3O4S | |
GC31689-5mg |
|
936350-00-4 |
Fiboflapon (GSK2190915)
|
0 | C38H43N3O4S | |
GC31689-2mg |
|
936350-00-4 |
Fiboflapon (GSK2190915)
|
0 | C38H43N3O4S | |
GC31689-10mM(1mLinDMSO) |
|
936350-00-4 |
Fiboflapon (GSK2190915)
|
0 | C38H43N3O4S | |
GC31688-100mg |
|
1820787-94-7 |
IRAK4-IN-1
|
0 | C19H23N5O | |
GC31688-50mg |
|
1820787-94-7 |
IRAK4-IN-1
|
0 | C19H23N5O | |
GC31688-25mg |
|
1820787-94-7 |
IRAK4-IN-1
|
0 | C19H23N5O | |
GC31688-10mg |
|
1820787-94-7 |
IRAK4-IN-1
|
0 | C19H23N5O | |